High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation: Preliminary results. Issue 1 (January 2020)

• Record Type: Journal Article
• Authors: Pisano, Giuseppina; Donato, Maria Francesca; Consonni, Dario; Oberti, Giovanna; Borroni, Vittorio; Lombardi, Rosa; Invernizzi, Federica; Bertelli, Cristina; Caccamo, Lucio; Porzio, Marianna; Dondossola, Daniele; Rossi, Giorgio; Fargion, Silvia; Fracanzani, Anna Ludovica
• Is Part Of: Digestive and liver disease. Volume 52:Issue 1(2020)
• Page Start: 84
• Page End: 90
• Publication Date: 2020-01
• Subjects: Carotid IMT -- EAT -- OLT -- Visceral adiposity atherosclerosis; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; 616.33005
• DOI: 10.1016/j.dld.2019.07.007
• Languages: English
• ISSNs: 1590-8658

Abstract

Abstract: Liver transplanted patients are at high risk of metabolic syndrome and its complications. We aimed to prospectively evaluate the early onset of cardiovascular alterations in patients submitted to the transplant waiting list. From January 2014 to January 2016, 54 out of 79 patients on the waiting list with decompensated cirrhosis or hepatocellular-carcinoma received the transplant, 50 were followed for 24 months, 2 died post-surgery and 2 were lost to follow-up. A significantly increased prevalence of visceral adiposity (epicardial adipose tissue thickness ( p = 0.001) and worsening of carotid damage ( p = 0.003) and diastolic dysfunction (E/A p = 0.001) was observed at 6 months after transplant and remained stable at 24 months, corresponding to an increased prevalence of diabetes, metabolic syndrome, hypertension and dyslipidemia. The duration of steroid therapy, withdrawn in the majority of patients at 3 months, did not influence cardiovascular damage. No significant difference in early progression of cardiovascular damage was observed between patients who did or did not receive a graft with steatosis. Conclusion: The occurrence of early cardiovascular alterations in the first 6 months after OLT accounts for the reported cardiovascular events in the first years after transplant. In light of these results, new strategies aimed at preventing or delaying cardiovascular alterations should be provided, starting from the first weeks after transplant.